Meet our Founder
Dr.Toyin Shonukan
Dr. Shonukan is a US board-certified Hematologist and Oncologist with extensive
experience in global clinical cancer research, therapeutic development, and Public Health.
After graduating from Medical School in Nigeria, she completed her post-graduate training
while serving the local communities at Columbia University and New York University. She
continued to provide medical care at Indian Reservations in the Dakotas and at St. Francis
Hospital in Zambia.
Upon returning to the US, she took on increasingly senior teaching responsibilities at
SUNY, Cornell University, and the University of Miami.
Joining international pharmaceutical companies such as Novartis, Takeda, and E. Lilly, she
led multi-disciplinary teams that advanced clinical development programs targeting breast
cancer, lymphoma, beta-thalassemia, Sickle Cell Disease, and others. Additionally, her
research has been published in peer-reviewed journals.
While completing a Master’s degree in Public Health from Boston University, she
investigated opportunities to enhance Women's cancer care in Nigeria.
This reflects her diverse experiences, which have culminated in the founding of the Women’s
Cancer Prevention Initiative, an organization dedicated to reducing the disproportionate burden
of cancers affecting women in Nigeria through health education, screening, and scientific
research.
